St. Jude wins FDA nod for next-gen defibrillators

06/12/2013 | RTT News

St. Jude Medical's Ellipse and SJM Assura line of implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators has been approved by the FDA. The next-generation devices come with a low-friction coating to help cut the risk for lead abrasion and feature technology designed to allow high-voltage treatment delivery.

View Full Article in:

RTT News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN